pierre fenaux (26 risultati)

Softcover. Condizione: Très bon. Ancien livre de bibliothèque. Edition 2012. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 2012. Ammareal gives back up to 15% of this item's net price to charity organizations.

Condizione: Bueno. : Hématologie es el cuarto libro de la colección Cancéroguides. Este libro trata sobre el linfoma no hodgkiniano, el mieloma múltiple, las leucemias agudas, los síndromes mielodisplásicos y agrupa un conjunto de datos más generales útiles en onco-hematología. La elaboración de esta guía ha sido colegiada, reuniendo a médicos que ejercen en el sector hospitalario o liberal, bajo la égida de un comité científico. EAN: 9782914206341 Tipo: Libros Categoría: Salud y Bienestar Título: Hématologie Autor: Pauline Brice| Pierre Fenaux| Thierry Lamy| Margaret Macro| Philippe Moreau Editorial: Margaux Orange Idioma: fr Páginas: 320 Formato: tapa blanda.

Hardcover. Condizione: Fine. Leichte Rillen / Abschürfungen / Risse / Knicke; Farbtonänderung. This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation. Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection.

Condizione: Neuf.

v, 157 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Condizione: very good. Photo non contractuelle. Envoi rapide et soigné.

Condizione: Bon Etat. ellipses In-8, broché, premier plat orné d'un portrait encadré à l'ovale de Molière, dense ouvrage de 224 pages, qq planches, bel exemplaire en bon état d'usage sans marque ni manque, frais en sa pagination. Bon Etat Epuisé et peu courant. *** PROCHAINE MISE A JOUR DU CATALOGUE LE 12 JUIN 2026 *** Paiement PayPal immédiat, Colissimo contre signature pour les envois de plus de 50 euros, Mondial Relay accepté pour : FRANCE Allemagne, Autriche, Belgique, Espagne, Italie, Portugal, Luxembourg, Pays-Bas, Pologne (Communiquer votre point ou locker si connu). Une participation supplémentaire peut être demandée pour les colis lourds hors France où les envois compris entre 5 et 25 kg sont dégressifs : 2 à 4 kilogrammes - 7.99 / 5 à 10 kg - 15.99 / 15 -25 kg - 25.99. Certaines de nos collections ( Vian, Céline, Camus (.) peuvent être expédiées en Franco de port. Pour l'international hors Europe (Suisse, Canada, Japon, Etats-Unis, les frais d'expéditions peuvent varier selon le poids (mise à jour : 1 juin 2026).

Condizione: fine. l'article peut presenter de tres legers signes d'usure. vendeur professionnel; envoi soigne en 24/48h.

Taschenbuch. Condizione: Neu. Myelodysplastic Syndromes | Diagnosis - Prognosis - Therapy | Uwe Platzbecker (u. a.) | Taschenbuch | Hematologic Malignancies | v | Englisch | 2018 | Springer | EAN 9783030083168 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Condizione: New. pp. V, 157 26 illus., 22 illus. in color. 1st ed. 2018 edition NO-PA16APR2015-KAP.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation. Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection.

Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation. Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection.

Comme neuf. [21034].

Paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Ellipses, 1983. Format 17,5x26 cm, broche, 192 pages. Exemplaire en etat d'usage. Etat correct.

Condizione: new. Questo è un articolo print on demand.

Condizione: new. Questo è un articolo print on demand.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation. Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection. 164 pp. Englisch.

Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation. Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection. 164 pp. Englisch.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides a comprehensive overview on all clinical aspects of myelodysplastic syndromes Presents novel therapeutic approaches Written by distinguished expertsUwe Platzbecker graduated from medical school in 1996 and then traine.

Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides a comprehensive overview on all clinical aspects of myelodysplastic syndromes Presents novel therapeutic approaches Written by distinguished expertsUwe Platzbecker graduated from medical school in 1996 and then traine.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation.Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 164 pp. Englisch.

Buch. Condizione: Neu. Myelodysplastic Syndromes | Diagnosis - Prognosis - Therapy | Uwe Platzbecker (u. a.) | Buch | Hematologic Malignancies | v | Englisch | 2018 | Springer | EAN 9783319768786 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

Condizione: New. Print on Demand pp. V, 157 26 illus., 22 illus. in color.

Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book reviews the standard diagnostic and therapeutic management of patients with myelodysplastic syndromes (MDS) and examines ongoing research developments in the field. The importance of appropriate prognostic stratification, taking into account recent advances in understanding of the molecular pathogenesis of MDS, is explained, and both established and novel treatment approaches are discussed in depth. The coverage includes, for example, the use of erythropoietic stimulating agents, iron chelation therapy, the immunomodulator lenalidomide, hypomethylating agents such as azacitidine, and allogeneic hematopoietic stem cell transplantation.Myelodysplastic syndromes are heterogeneous and complex hematologic disorders ranging from indolent conditions to forms approaching the aggressiveness of acute myeloid leukemia. The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies. Hematologists, oncologists, and other interested clinicians will find this book to be an invaluable source of information on diagnostic and prognostic evaluation and treatment selection.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 164 pp. Englisch.

Condizione: New. PRINT ON DEMAND pp. V, 157 26 illus., 22 illus. in color.